PUBLISHER: The Business Research Company | PRODUCT CODE: 1889489
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889489
Ingestible biosensors are advanced medical devices that can be safely swallowed and move through the gastrointestinal tract, where they continuously track physiological parameters such as pH, temperature, pressure, or specific biomarkers. These sensors transmit real-time data to external devices, allowing physicians to evaluate digestive health, identify abnormalities, and tailor personalized treatment plans while reducing reliance on invasive procedures.
The main components of ingestible biosensors include capsule biosensors, pill biosensors, and others. Ingestible biosensors, or capsule biosensors, are swallowable devices equipped with sensors that measure physiological or biochemical conditions inside the gastrointestinal tract and transmit the information for diagnostic or therapeutic use. The various sensor types include temperature sensors, pH sensors, image sensors, and others. They are used in several applications, including medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, and serve end-users such as hospitals and clinics, research institutes, home care settings, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The ingestible biosensors market research report is one of a series of new reports from The Business Research Company that provides ingestible biosensors market statistics, including ingestible biosensors industry global market size, regional shares, competitors with a ingestible biosensors market share, detailed ingestible biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the ingestible biosensors industry. This ingestible biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ingestible biosensors market size has grown rapidly in recent years. It will grow from $1.78 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period resulted from the rising success of capsule endoscopy, growing focus on medication adherence, increasing progress in wireless telemetry, early Food and Drug Administration approvals, and expanding research and development in digital health.
The ingestible biosensors market size is expected to see rapid growth in the next few years. It will grow to $2.93 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period will be driven by the rising prevalence of chronic diseases, growing adoption of remote monitoring, increasing development of miniaturized electronics, strengthening regulatory support, and the continued digitization of healthcare. Major trends in the forecast period include advancements in AI-enabled data analytics, integration of sensing and drug delivery technologies, innovation through medtech-pharma collaborations, technological expansion into emerging markets, and progress in multi-parameter sensing.
The growing awareness of real-time monitoring is expected to drive the growth of the ingestible biosensors market. Real-time monitoring involves the continuous collection, analysis, and transmission of data as it is generated, enabling immediate health assessment and timely medical intervention. Awareness of real-time monitoring is rising due to the increasing focus on proactive healthcare management, as patients and healthcare providers recognize its value in enabling early detection of health issues and prompt medical responses. Ingestible biosensors facilitate real-time monitoring by transmitting physiological data from inside the body, allowing continuous tracking of parameters such as medication adherence, gastrointestinal activity, and biomarker levels for timely diagnosis and personalized treatment. For example, in October 2024, HealthArc, a US-based healthcare solutions provider, reported that approximately 30 million patients in the U.S. were using remote patient monitoring (RPM), with the number expected to increase to 70.6 million by the end of 2025. Additionally, 42 states have included RPM under Medicaid coverage, and more than 26% of Americans are anticipated to adopt it. Therefore, the increasing awareness of real-time monitoring is fueling the growth of the ingestible biosensors market.
Key companies operating in the ingestible biosensors market are focusing on developing innovative solutions, such as vitals-monitoring pills, to improve real-time health tracking and early disease detection. Vitals-monitoring pills are ingestible electronic capsules that track key physiological parameters, such as heart rate, and transmit real-time health data to external devices for monitoring and analysis. For instance, in November 2023, Celero Solutions Inc., a Canada-based information technology company, developed an ingestible electronic capsule, roughly the size of a multivitamin, capable of measuring heart and breathing rates from within the gastrointestinal tract. In a first-in-human trial involving ten participants, the device reliably detected breathing depressions, such as those occurring in obstructive sleep apnea and potentially in opioid overdose scenarios. The sensor uses an internal accelerometer and wireless transmission to capture vital-sign data and safely passes through the digestive tract without adverse effects. Researchers envision this technology being used for non-intrusive monitoring of respiratory status and potentially triggering interventions in high-risk patients.
In May 2025, imec VZW, a Belgium-based non-profit research and technology organization, partnered with OnePlanet Research Center to advance sustainable technology solutions by leveraging its expertise in nanoelectronics and digital innovations. This collaboration focuses on developing impactful and environmentally responsible healthcare solutions, including ingestible biosensors that enable real-time monitoring of vital signs and gastrointestinal health. OnePlanet Research Center, based in the Netherlands, is a multidisciplinary innovation and research institute specializing in advanced healthcare technologies.
Major companies operating in the ingestible biosensors market are Medtronic PLC, Koninklijke Philips N.V., Otsuka Holdings Co. Ltd., Olympus Corporation, Verily Life Sciences LLC, CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., Shenzhen Jifu Medical Technology Co. Ltd., AnX Robotica Corporation, Atmo Biosciences Pty Ltd, Chongqing Jinshan Science & Technology (Group) Co., Ltd., EnteraSense Limited, etectRx Inc., LUCID MEDICAL DIAGNOSTICS PRIVATE LIMITED, Check-Cap Ltd., Sencure B.V., HQ Inc., Jinshan Science & Technology, Bio-Images Research Limited (BIRL).
North America was the largest region in the ingestible biosensors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ingestible biosensors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ingestible biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ingestible biosensors market consists of sales of ingestible sensor devices, including capsule-based sensors, electronic pills, and smart drug delivery systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ingestible Biosensors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ingestible biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ingestible biosensors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ingestible biosensors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.